Fast Growing Networked Life Sciences Platform Company Eagle Genomics Adds 3 New U.S. Advisory Board Members To Global Panel

The success of the UK scale-up has attracted figures from international business development, pharmaceutical business strategy and nutritional innovation to San Diego, Cambridge Massachusetts, and new York to help shape the next phase of its global growth

CAMBRIDGE, United Kingdom, May 11, 2021 / PRNewswire / – Eagle Genomics, a Pioneer in the Application of Network Science to Biology, Announced the Appointment of Three Prestigious US-Based Advisory Board Members to its Global Panel, to Help Shape the Next Phase of its international growth. The move comes as the world’s leading food, personal care and agricultural biotechnology (AgBio) brands look to play their part in addressing real-world challenges with innovative, sustainable and next-generation products. that work in symbiosis with the microbiome.

Kelly C. Huang, situated at San Diego, California, is Co-Chair of Boardroom Ready at Women In Bio, an organization of professionals dedicated to promoting the careers, leadership and entrepreneurship of women in the life sciences. In this role, she coordinates training, mentoring and indoor events for female life science executives who wish to serve on boards of directors. Of 101 women enrolled in the program, 70+ have secured positions on private and public life science boards. Early in her career, Kelly established critical business development relationships for IBM and Monsanto with JV partners and clients. Most recently as a leadership coach and speaker, she has made the headlines at Qualcomm, IEEE and Women in Tech.

Jim frates, Chief Financial Officer at Amylyx Pharmaceuticals in Cambridge, Massachusetts, began his career in biotechnology investment banking before becoming more entrenched in the industry in corporate finance leadership roles. These included 23 years as CFO at Alkermes, seeing through its growth from a clinical stage company to an international trade and development company with multiple products, returning $ 1 billion in turnover and employing more than 2,000 people. Jim joined Amylyx earlier this year – a company specializing in the development of new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases.

Joshua anthony, based in the New York City Metropolitan Area, is a scientist, innovator and entrepreneur and founder / CEO of personalized nutrition innovation start-up, Nlumn. The company collaborates with food, nutrition and health technology companies to create new opportunities in the personalized nutrition and health market that help consumers achieve their health and functional goals. . Over the past two decades, Josh has led all phases of the product lifecycle, from discovery to commercialization, for companies in the food and nutrition industry including Campbell Soup Company, Mead Johnson Nutrition and Unilever, as well as personalized nutrition start-up Habit.

New appointments come as Eagle Genomics accelerates growth ambitions and helps more global brands innovate with microbiome-friendly science, with the company pioneering e[datascientist]â„¢ Knowledge discovery platform for networking and exploring supporting science.

Commenting on the announcement of additional Eagle Genomics advisors, Anthony finbow, the CEO of the Company, said: “We are delighted to welcome such deep and diverse expertise and experience to our Advisory Board as Eagle Genomics outlines its growth strategy for the next phase of its expansion. Kelly, Jim and Josh each bring their unique perspective on the biological revolution and the associated opportunity both for our business and for the clients we work with. Together, they will provide an invaluable sounding board and source of commentary, adding to the already strong roster of board advisors we have in place. “

The three new US advisers join existing panel members Greg Bodine, Chief Cloud and IT Officer at the patient analysis specialist, Excelicare, in Cary, North Carolina; Bettina goerner, Chief Data Officer at Centogene (Diagnostics & Genomics), in Heidelberg, Baden-Württemberg in Germany; and David Cleevely, who, among many prestigious roles during his career, co-founded the web-based antibody company Abcam (ABC.L), is a fellow of the Royal Academy of Engineering and the IET, and in 2009, was appointed founding director and member of the executive committee of the Center for Science and Policy at Cambridge University.

Eagle Genomics, which has ambitious plans for customer-driven global growth as the biological revolution continues to transform the global economy, recently announced plans for significant expansion in India within the innovation hub of Laxmi Cyber ​​City in Hyderabad, a major center for the technology and biotechnology industries. The company, which will soon launch a new major financing round, already has a hub in new York Genome Center and other bases in France and Germany.

About Eagle Genomics
Eagle Genomics, headquartered at Cambridge, UK, innovates at the intersection of biology, data science and bioinformatics. The company specializes in providing powerful business platform solutions for innovation in the age of microbiomics and genomics. Award winning sound[1] AI-augmented knowledge discovery platform, e[datascientist]â„¢, helps companies drive science-based innovations for next-generation agrifood, personal care, cosmetics and agricultural biotechnology (AgBio) products. The platform harnesses the science of causal networks and advanced machine learning and cognitive services.

Eagle Genomics was founded in 2008 with a focus on the discovery of human DNA in biotechnology and pharmacy, before relaunching nearly a decade later with a new mission – to apply the science of networks to discovery related to the microbiome. Today, the rapidly growing global company operates out of the world’s leading genomics and AI centers. These included Cambridge’s Wellcome BioData Innovation Center and London Knowledge Quarter in the UK; Microsoft’s AI factory in Paris; Potsdam Science Park; JLABS in new York, and the new installation of Laxmi Cyber ​​City in Hyderabad, India.

Eagle Genomics works with the world’s largest food and personal care companies to create and launch new products that work in harmony with the human and ecological microbiome. Learn more at

[1] “Best of Show” from BioIT World; Hello tomorrow Top 500 Deeptech Startup, Microsoft AI Factory, EIT Food Rising Star, WBCSD FReSH Gamechanger

Logo –

SOURCE Eagle Genomics

About Margie Peters

Check Also

My day: Grainne Hughes, Almac Pharma Services

At 8am, I’m in my car and already halfway from the office to Almac’s headquarters …

Leave a Reply

Your email address will not be published.